Innogen Pharma Added to Stock Connect Programs

MT Newswires Live
2025/12/08

Guangzhou Innogen Pharmaceutical (HKG:2591) said its H shares have been added to both the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, effective Monday, according to a same-day bourse filing.

The inclusion will allow mainland investors to trade the company's H shares through the Shanghai and Shenzhen stock exchanges.

The board said the move is expected to broaden the firm's investor base, boost liquidity, and strengthen its profile in the capital market.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10